Back to search
Systemic Lupus Erthematosus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Lupus Erthematosus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Systemic Lupus Erthematosus trials you may qualify forBackground: The cause of fatigue is not well understood. It can be felt differently by different people. Some people think there are different types of fatigue…
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for pati…
This is an exploratory, open-label, single-arm Phase 1 clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of QT-219C. QT-219…
This Phase 1, open label, dose escalation study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of HB2…
The goal of this pragmatic embedded open-label, 2 x 2 factorial phase II randomized controlled trial is to evaluate strategies to improve COVID-19 booster and i…
to evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
Budoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that selectively binds to CD19 and is projected to deplete targeted cells through antibody…
The goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics profile of KN5501 cell injection in adults with systemic lup…
Systemic lupus erythematosus (SLE) is a life-long systemic autoimmune disease with a large variability in its clinical course. The onset of SLE during childhood…